Literature DB >> 19019499

[Inappropriate low glycated hemoglobin and hemolysis].

A Debard1, S Charmion, S Ben Ameur, J-B Gaultier, P Cathébras.   

Abstract

Hemoglobin A1c (HbA1c), measured regularly in the patients with diabetes, is the major form of stable glycated hemoglobin and has to be maintained below 6.5% to prevent or decrease the risk of chronic complications. HbA1c reflects mean blood glucose levels of the previous 3 months. We report the case of a particularly low HbA1c in a diabetic patient despite high plasma glucose levels, that was induced by auto-immune hemolysis related to an Evans syndrome. All hemolytic disorders can be responsible for falsely reassuring HbA1c values. Clinicians must be aware that hematologic status has to be considered for the correct interpretation of HbA1c results.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19019499     DOI: 10.1016/j.revmed.2008.10.010

Source DB:  PubMed          Journal:  Rev Med Interne        ISSN: 0248-8663            Impact factor:   0.728


  2 in total

1.  Immeasurable glycosylated haemoglobin: a marker for severe haemolysis.

Authors:  Nidhi Aggarwal; Anand Kumar Rai; Yizhak Kupfer; Sidney Tessler
Journal:  BMJ Case Rep       Date:  2013-08-08

2.  The ICET-A Recommendations for the Diagnosis and Management of Disturbances of Glucose Homeostasis in Thalassemia Major Patients.

Authors:  Vincenzo De Sanctis; Ashraf T Soliman; Heba Elsedfy; Saif Al Yaarubi; Nicos Skordis; Doaa Khater; Mohamed El Kholy; Iva Stoeva; Bernadette Fiscina; Michael Angastiniotis; Shahina Daar; Christos Kattamis
Journal:  Mediterr J Hematol Infect Dis       Date:  2016-10-28       Impact factor: 2.576

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.